Lori Rice Selected Research

Pathologic Neovascularization

1/2013

Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lori Rice Research Topics

Disease

9	Neoplasms (Cancer) 08/2021 - 08/2002
5	Prostatic Neoplasms (Prostate Cancer) 06/2016 - 08/2002
3	Neoplasm Metastasis (Metastasis) 08/2021 - 11/2010
2	Sarcoma (Soft Tissue Sarcoma) 01/2014 - 11/2010
1	Acute Radiation Syndrome 01/2022
1	Cardiotoxicity 08/2021
1	Disease Progression 06/2016
1	Pathologic Neovascularization 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Necrosis 01/2011
1	Fibrosarcoma 11/2010
1	Adenocarcinoma 08/2002

Drug/Important Bio-Agent (IBA)

3	IsoflavonesIBA 04/2007 - 08/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 11/2010
2	AndrogensIBA 04/2007 - 01/2006
1	Peptides (Polypeptides)IBA 01/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021
1	Cathepsin LIBA 06/2016
1	KGP94IBA 06/2016
1	Peptide Hydrolases (Proteases)FDA Link 06/2016
1	AlbuminsIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 02/2012
1	TubulinIBA 01/2011
1	Oxi 4503IBA 01/2011
1	combretastatinIBA 01/2011
1	saracatinibIBA 11/2010
1	Interleukin-8 (Interleukin 8)IBA 01/2006
1	biochanin AIBA 08/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2021
1	Therapeutics 08/2021